246 related articles for article (PubMed ID: 29416431)
1. Immunophenotypic features of dedifferentiated skull base chordoma: An insight into the intratumoural heterogeneity.
Batista KMP; Reyes KYA; Lopez FP; Pelaz AC; Vega IF; Pendás JLL; Ayala AS; Astudillo A; Rojas JAN; Fernandez PB
Contemp Oncol (Pozn); 2017; 21(4):267-273. PubMed ID: 29416431
[TBL] [Abstract][Full Text] [Related]
2. Revisiting chordoma with brachyury, a "new age" marker: analysis of a validation study on 51 cases.
Jambhekar NA; Rekhi B; Thorat K; Dikshit R; Agrawal M; Puri A
Arch Pathol Lab Med; 2010 Aug; 134(8):1181-7. PubMed ID: 20670140
[TBL] [Abstract][Full Text] [Related]
3. [Chordoma].
George B; Bresson D; Bouazza S; Froelich S; Mandonnet E; Hamdi S; Orabi M; Polivka M; Cazorla A; Adle-Biassette H; Guichard JP; Duet M; Gayat E; Vallée F; Canova CH; Riet F; Bolle S; Calugaru V; Dendale R; Mazeron JJ; Feuvret L; Boissier E; Vignot S; Puget S; Sainte-Rose C; Beccaria K
Neurochirurgie; 2014 Jun; 60(3):63-140. PubMed ID: 24856008
[TBL] [Abstract][Full Text] [Related]
4. [Chordoma: is there a molecular basis for diagnosis and treatment?].
Scheipl S; Igrec J; Leithner A; Smolle M; Haybäck J; Liegl B
Pathologe; 2020 Mar; 41(2):153-162. PubMed ID: 32100085
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of a chordoma cell line from the tissue of a patient with dedifferentiated-type chordoma.
Kim JY; Lee J; Koh JS; Park MJ; Chang UK
J Neurosurg Spine; 2016 Nov; 25(5):626-635. PubMed ID: 27314550
[TBL] [Abstract][Full Text] [Related]
6. Chordoma: the nonsarcoma primary bone tumor.
Chugh R; Tawbi H; Lucas DR; Biermann JS; Schuetze SM; Baker LH
Oncologist; 2007 Nov; 12(11):1344-50. PubMed ID: 18055855
[TBL] [Abstract][Full Text] [Related]
7. Dedifferentiated Chordoma: Clinicopathologic and Molecular Characteristics With Integrative Analysis.
Hung YP; Diaz-Perez JA; Cote GM; Wejde J; Schwab JH; Nardi V; Chebib IA; Deshpande V; Selig MK; Bredella MA; Rosenberg AE; Nielsen GP
Am J Surg Pathol; 2020 Sep; 44(9):1213-1223. PubMed ID: 32427623
[TBL] [Abstract][Full Text] [Related]
8. Chordoma: Immunohistochemical Analysis of Brachury.
Sun HI; Guduk M; Gucyetmez B; Yapicier O; Pamir MN
Turk Neurosurg; 2018; 28(2):174-178. PubMed ID: 28094431
[TBL] [Abstract][Full Text] [Related]
9. Diagnosing an extra-axial chordoma of the proximal tibia with the help of brachyury, a molecule required for notochordal differentiation.
O'donnell P; Tirabosco R; Vujovic S; Bartlett W; Briggs TW; Henderson S; Boshoff C; Flanagan AM
Skeletal Radiol; 2007 Jan; 36(1):59-65. PubMed ID: 16810540
[TBL] [Abstract][Full Text] [Related]
10. Tumor-biology and current treatment of skull-base chordomas.
Pamir MN; Ozduman K
Adv Tech Stand Neurosurg; 2008; 33():35-129. PubMed ID: 18383812
[TBL] [Abstract][Full Text] [Related]
11. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas.
Vujovic S; Henderson S; Presneau N; Odell E; Jacques TS; Tirabosco R; Boshoff C; Flanagan AM
J Pathol; 2006 Jun; 209(2):157-65. PubMed ID: 16538613
[TBL] [Abstract][Full Text] [Related]
12. [Chordoma as a neurosurgical pathology].
Sidorin VS; Efimov AV; Strelkina KA; Sokolova TV; Orlov AY; Zabrodskaya YM
Arkh Patol; 2022; 84(3):24-31. PubMed ID: 35639840
[TBL] [Abstract][Full Text] [Related]
13. Unraveling molecular advancements in chordoma tumorigenesis and treatment response: a review of scientific discoveries and clinical implications.
Jin MC; Connolly ID; Ravi K; Tobert DG; MacDonald SM; Shin JH
Neurosurg Focus; 2024 May; 56(5):E18. PubMed ID: 38691860
[TBL] [Abstract][Full Text] [Related]
14. Targeting mTOR Pathway in PTEN Deleted Newly Isolated Chordoma Cell Line.
Pagani F; Gryzik M; Somenza E; Cominelli M; Balzarini P; Schreiber A; Mattavelli D; Nicolai P; Doglietto F; Poliani PL
J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983607
[TBL] [Abstract][Full Text] [Related]
15. Skull base chordomas review of current treatment paradigms.
Yaniv D; Soudry E; Strenov Y; Cohen MA; Mizrachi A
World J Otorhinolaryngol Head Neck Surg; 2020 Jun; 6(2):125-131. PubMed ID: 32596658
[TBL] [Abstract][Full Text] [Related]
16. Chordoma: the entity.
Yakkioui Y; van Overbeeke JJ; Santegoeds R; van Engeland M; Temel Y
Biochim Biophys Acta; 2014 Dec; 1846(2):655-69. PubMed ID: 25193090
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic features of four rare types of chordomas, confirmed by brachyury immunostaining.
Rekhi B; Banerjee D; Ramadwar M; Bajpai J; Jambhekar NA
Indian J Pathol Microbiol; 2017; 60(3):350-354. PubMed ID: 28937370
[TBL] [Abstract][Full Text] [Related]
18. Differences in sex distribution, anatomic location and MR imaging appearance of pediatric compared to adult chordomas.
Sebro R; DeLaney T; Hornicek F; Schwab J; Choy E; Nielsen GP; Rosenthal DI
BMC Med Imaging; 2016 Sep; 16(1):53. PubMed ID: 27609115
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome comparison identifies potential biomarkers of spine and skull base chordomas.
Bell AH; DeMonte F; Raza SM; Rhines LD; Tatsui CE; Prieto VG; Fuller GN; Bell D
Virchows Arch; 2018 Mar; 472(3):489-497. PubMed ID: 28844110
[TBL] [Abstract][Full Text] [Related]
20. [Chordoma-An update].
Mellert K; Seeling C; Möller P; Barth TFE
Pathologie (Heidelb); 2022 Aug; 43(Suppl 1):50-55. PubMed ID: 36175666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
